Scroll to top

Scroll to top

News Releases

Home
Investors
News Releases

News Releases

Month Year

Month Year

Investor Alerts

November 19, 2019

Immunic, Inc. Expands Board of Directors with Appointment of Biotechnology Executive Barclay A. Phillips
November 7, 2019

Immunic, Inc. Reports Third Quarter 2019 Financial Results and Highlights Recent Activity
November 5, 2019

Immunic, Inc. to Participate in Industry and Investor Conferences in November
October 15, 2019

Immunic, Inc. Expands Board of Directors with Appointment of Industry Veteran Tamar Howson
October 10, 2019

Immunic, Inc. Announces Completion of Enrollment for its Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis

- Milestone Achieved Nine Months Ahead of Initial Schedule; Top-Line Data Expected in Q3 2020 -

Show per page